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Introduction
Tobacco smoking today is recognised as a manifestation of
nicotine addiction and thus as a treatable chronic condition1,2.
A number of interventions have been shown to help people stop
smoking3, with two of the most successful being group behaviour
therapy programmes4 and nicotine replacement therapy (NRT) 5,
both individually and more so in combination6,7.   Another ef-
fective form of pharmacotherapy, bupropion1,6, was not yet avail-
able in Malta at the time of this study.
In Malta, while 38% of 25-64 year old men and 17% of
women (of the same age) smoked in 19958, 32% of schoolchil-
dren aged 11-16 smoked cigarettes in 19989.   The number of
yearly deaths in Malta attributable to smoking has risen by 28%
from 289 in 1987 to 371 in 1999, i.e. approximately one death a
day (Agius Muscat H, personal communication, 2000).   On
the other hand, 72% of Maltese smokers do consider they would
be much healthier after quitting, with about nine in ten believ-
ing in quitting with help and having tried quitting more than
once, and over half thinking they would not be smoking a year
later10.
Arising out of the above needs, smoking cessation clinics in
Malta have been organised on a regular basis in government
health centres by the Department of Health Promotion since
1991.   Based on the Prochaska & Diclemente ‘stages of change’
model (see Figure 1), the programme of these clinics (Table 1)
was adapted from that described by Steele12.   It consists of seven
group-counselling sessions (reduced to five in 2000) where
behavioural treatment is combined with nicotine replacement
therapy.
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Abstract
Introduction. Smoking cessation clinics in Malta have
been organised by the Health Promotion Department in
government primary health care centres on a regular basis since
1991.
Aim. A research project was set up to evaluate the clinics’
process, outcome and consequent cost-benefit.
Methods. The qualitative procedure involved question-
naire completion and interpretation by a total of 40 clients who
attended the last session of all clinics held during one year from
October 1999.   The quantitative method entailed measurement
and analysis of participants’ smoking status at the quit session,
final session and following a six-month period.
Results. The thirty participants (75% response rate) who
completed the questionnaire spoke quite favourably of the clinic
process.   Of the 101 clients attending quit sessions, there were
27 quitters by the final session (giving an immediate success
rate of 27%), and only ten were still not smoking at the six-month
follow-up (long-term success rate of 10%).
Discussion. The consequent savings to lung cancer treat-
ment were conservatively estimated at Lm 3245 during the first
year of diagnosed disease, more than five times the clinics’ run-
ning costs over one year.   Recommendations for service im-
provement include:
• The integral use of pharmacotherapy and carbon monoxide
monitoring;
• The organisation of clinics on a more frequent basis, with
follow-up support meetings;
• The setting-up of state-of-the-art training for facilitators;
• The introduction of an on-going quantitative and qualita-
tive evaluation system;
• The classification of nicotine addiction as a Schedule 5 dis-
ease to enable pharmacotherapy to be available free on pre-
scription; and
• Full support and funding of smoking cessation and other
tobacco control services.
Table 1: Smoking Cessation Clinic Programme,
Health Promotion Department
Session 1 Introduction
Session 2 After one week Quit Day
Session 3 After one week Follow-Up
Session 4 After one week Follow-Up
Session 5 After two weeks Follow-Up
Session 6 After two weeks Follow-Up
Session 7 After two weeks Final session
NB: The first clinic (in the series of 13 evaluated)
ended at the 6th session, while the last 4 clinics
were reduced from 7 to 5 sessions.
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Figure 1: Process of changes of attitude in stopping smoking (adapted from Raw11).
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Relapsing
Clinics Original Attended Attended Attended Quit smoking Immediate Still not smoking
date, venue, Number of Intro Quit Final by Final Success after 6 months
facilitator Applicants Session Session Session Session Rate
initials No 1 No 2 No 5/7* % Quit Sess. % Quit Sess. % Quit Sess.
Table 2: Participation and success rates of smoking cessation clinics held by the Health Promotion Department
over one year starting in October 1999
Oct-Dec 1999
Gzira (MS) 18 10 11 6 6 55% 3 27%
Feb-Apr 2000
Qormi (AB) 24 11 10 3 3 30% 3 30%
Feb-Apr 2000
Mosta (AB) 22 7 5 3 3 60% 1 20%
Feb-Apr 2000
Mosta (LB) 13 7 6 3 2 33% 0 0%
Feb-Apr 2000
Floriana 1 (MC) 21 4 4 2 2 50% 0 0%
Feb-Apr 2000
Floriana 2 (MC) 15 6 2 0 0 0% 0 0%
Feb-Apr 2000
Paola 1 (AL) 26 12 9 0 0 0% 0 0%
Feb-Apr 2000
Paola 2 (AL) 22 10 9 2 0 0% 0 0%
Feb-Apr 2000
Gzira (JB) 14 9 4 0 0 0% 0 0%
May-Jun 2000
Mosta (JB) 18 11 5 1 0 0% 0 0%
May-Jun 2000
Paola (RB) 26 24 17 9 6 35% 3 18%
May-Jun 2000
Gzira (AB) 7 7 6 3 2 33% 0 0%
May-Jun 2000
Floriana (LB) 20 16 13 8 3 23% 0 0%
Total 246 134 101 40 27 27% 10 10%
* Clinic held on Oct-Dec 1999 in Gzira was 6 sessions long, and clinics starting in May 2000 were reduced from 7 to 5 sessions.
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Rationale & Purpose of Study
As smoking cessation/reduction treatments provide qual-
ity-of-life benefits to the individual and economic benefits to
the country, the need for development and evaluation of such
interventions has been emphasised13.
The purpose of this study was to evaluate the process, long-
term outcome and effectiveness (including success, satisfaction
and costs) of local smoking cessation clinics, and enable the
Health Promotion Department to confirm its strategy of
organising such a service while making any necessary changes
to improve it.   After establishing the clinics’ performance, this
was compared against the expected standards, and appropriate
action recommended.
Methods
This study evaluated clinics organised by the Health Pro-
motion Department over one year starting in October 1999.   The
qualitative section of this evaluation entailed questionnaire
completion and interpretation, and involved participants who
attended the final session of these clinics.   The quitters among
them were followed up at six months after the end of each clinic
to fulfil the criteria for the quantitative part of the research
project through measurement and analysis of their smoking
status.   Other forms of evaluation (including facilitator assess-
ment / rating, and subjective assessment and peer review) were
not considered in this project.
Quantitative
In order to assess the smoking status of each client, the
locally-trained facilitators asked the following question at each
session of the clinic:
• How many cigarettes do you smoke daily?
At six months after the end of the clinic, the author tele-
phoned those clients who had quit smoking by the final session
and asked them:
• Are you smoking?
• If so, how many cigarettes per day?
• If not, when did you stop?
• If you stopped, did you use nicotine replacement therapy?
Dropouts whose smoking status at follow-up was not known
were counted as smokers14.
The immediate impact was taken as the number of quitters
at the final session compared to the baseline number of partici-
pants attending the ‘quit’ session.   Quitters must have not
smoked at all during the previous two weeks14.
The main long-term outcome measure was abstinence from
smoking at six months from the end of the clinic compared to
Table 3: Themes arising from replies to questionnaires
Aspects of the meetings liked:
• Meetings in general, and facilitators in particular
• Teaching and explanations,
with the video as a teaching aid
• Quitting as a collective effort in a group
Most important changes made during the weeks attended:
• Physical changes: stopping smoking /
smoking less / health-related changes
• Psychological changes: role of programme /
personal roles
Future plans to remain healthy:
• Not smoking again / stopping completely
• Healthy food / exercise
• On-going psychological battle / assistance to others
Gender Age (yrs) Age (yrs) Cumulative Cumulative Decrease Estimated Estimated
of quitters when to nearest risk of lung risk if had in risk cost (Lm) of savings (Lm)
stopped decade cancer* smoked consequent treatment per per quitter
(A) till 75 yrs to quitting patient for first (DxC)
(B) (B-A=C) year of diagnosed
disease** (D)
Table 4: Estimation of savings in lung cancer treatment (first year of diagnosed disease) for the Maltese public health
system resulting from smoking cessation clinics (October 1999 - September 2000)
F 52 50 2.20% 9.50% 7.30% 3160 231
F 55 50 2.20% 9.50% 7.30% 3160 231
F 64 60 5.30% 9.50% 4.20% 3160 133
M 30 30 1.70% 15.90% 14.20% 3160 449
M 30 30 1.70% 15.90% 14.20% 3160 449
M 37 40 3.00% 15.90% 12.90% 3160 408
M 44 40 3.00% 15.90% 12.90% 3160 408
M 49 50 6.00% 15.90% 9.90% 3160 313
M 50 50 6.00% 15.90% 9.90% 3160 313
M 54 50 6.00% 15.90% 9.90% 3160 313
TOTAL Lm3245
* From Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R 21
** Lm286,000 divided between 104 smokers during 1995 (source: university dissertation 20), and adjusted for inflation.22
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the baseline4,5.   Both point-prevalent abstinence (at the time of
asking) and continuous abstinence (throughout the previous six
months) were assessed.
Analysis and presentation of data was performed on com-
puter using the spreadsheet software, Microsoft Excel 97 Æ.
Qualitative
An anonymous evaluation form compiled by the Health
Promotion Department was given to participants to complete
at the end of the final session.   The form consisted of three
open-ended questions, presented in Maltese:
• What aspects of the meetings did you like most?
• What were the most important changes you made during
the weeks attended?
• What are your plans for the future in order to remain
healthy?
The analysis of the questionnaires was performed in two
stages.   First, key data were highlighted in the replies to each
question to enable cross analysis on a case-by-case basis - this
is termed ‘data reduction’.   In the second stage, called ‘data
interpretation’, a model or table was used to present in a lucid
manner the differences and similarities within the clients’ rec-
ommendations, thus allowing any trends to be more easily iden-
tified and interpreted15.
Ethical considerations
Participants were informed that they would be part of a vol-
untary research study that would assist the Department to evalu-
ate and improve the service provided by smoking cessation clin-
ics in Malta.   The completion of the anonymous evaluation
forms during the final session of the clinic was entirely volun-
tary and participants could refuse to answer all or any specific
questions.   The confidentiality of participants was ensured as
the answers to questions were not given to anybody else out-
side the research team, and no reports of this study would ever
identify participants in any way.
Results
Quantitative Results
There were 246 applicants who applied for the 13 smoking
cessation clinics organised by the Health Promotion Depart-
ment in Malta during the year starting in October 1999.   Out
of these, only 134 presented themselves for the introductory
session, with this number falling to 101 for Session No. 2 -
the quit session (see Table 2).   While the immediate success
rate at the final session was 27% (n=27) as a percentage of
the participants attending the quit session, the six-month
success rate dropped to 10% (n=10), with dropouts being
counted as smokers.
Of these ten quitters who were still not smoking at six
months after the end of the clinic:
• seven were males, while three were females;
Table 5: Estimation of cost of smoking cessation clinics
(October 1999 – September 2000)
Clinics Number of 2-hour sessions
Total number of sessions 79
Cost per 2 hour session* Lm8
Total Clinic Cost Lm632
* Cost estimated from tuition fee paid to smoking cessation
facilitators, and excludes the setting-up expenses (training,
video-players, video-cassettes, monitors, whiteboards) incurred
once only in 1991, and other minimal running costs (handouts,
writing materials).
Table 6: Recommendations of study
Section Recommendations
Content • The use of pharmacotherapy (NRT
and/or bupropion) as a cornerstone of
smoking cessation clinics.
• Carbon monoxide monitoring
should be used routinely in each session
of every clinic as a motivational tool.
• Questionnaires used for qualitative
evaluation should be structured to
allow both positive and negative
feedback.
Operations • Frequent clinics (e.g. every month)
should be held in one central venue
furnished with facilities for audio-visual
aids.
• Follow-up support meetings should
be offered at various times after course-
completion, e.g. every month for up to
12 months.
• State-of-the-art training should be
provided to facilitators on a regular
basis.
• Quantitative evaluation should be
carried out on an on-going basis, with
validation of cessation and follow-up.
Finance • Investment in smoking cessation
should be maximised to the benefit of
the health and economy of the nation.
Strategy • The classification of nicotine addic-
tion as a Schedule 5 Disease to
make NRT products (together with
bupropion) available free by
prescription on this Schedule.
• The Health Division should lend its full
support to the Health Promotion
Department for its smoking cessation
programme together with the other
tobacco-related strategies.
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• three were aged 30-39 years (30%), two were between 40
and 49 years old (20%), four were in their 50’s (40%), and
one was 64 years old;
• nine were continuously abstinent for the whole duration of
the six months (one male had re-started smoking, only to
quit again 3 months before the six-month follow-up);
• and only two (20%) had used nicotine replacement therapy
as an aid to stopping.
Also of note is the fact that 9 of the 13 clinics provided no
quitters at 6 months, as the ten long-term quitters all came from
just four clinics.
Qualitative Results
Of the 40 clients who attended the last session of the smok-
ing cessation clinics reviewed, 30 participants completed the
questionnaire, giving a 75% response rate.   The themes arising
from the questionnaire replies are summarised in Table 3.
Discussion
Implications for improving the outcome
The 10% prevalent abstinence rate (9% continuous absti-
nence rate) at six months after the end of the Malta clinics is
low compared to international standards (20-30% in the UK16
and 15-30% in the USA1), particularly as these are measured at
one year, and assuming no differences in the methods used and
their application.
One significant factor that may account for this difference
is the freedom of choice for use of pharmacotherapy (in this
case, nicotine replacement therapy).   While UK and US recom-
mendations1,6,7,14,17 put pharmacotherapy (NRT and bupropion)
as the cornerstone of therapy, Maltese smoking cessation clin-
ics still leave the choice for use or non-use of NRT to the par-
ticipants.   In fact, of the 10 quitters who were not smoking at
six months after the end of their respective clinics, only two
(20%) had used nicotine replacement therapy.
While fear of the side effects of NRT (as explained before
use by facilitators) may be one reason for this, another perhaps
more significant reason may be its high cost, which has to be
borne by the would-be quitters.   In this regard, the Maltese
Health Division would do well to follow the lead of the UK Na-
tional Health Service (NHS), which has recognised the cost-ef-
fectiveness of NRT products by making them available for NHS
prescription by general practitioners14,18.
Another factor that may improve quit rate is the routine use
(in each session of every clinic) of carbon monoxide monitors
to monitor the level of participants’ exhaled carbon monoxide.
This is accepted as being good practice in view of its usefulness
as a motivational tool for clients, besides being helpful to vali-
date quit rates14.
Further investigation needs to be carried out in the form of
a comparative evaluation of each session and facilitator to clarify
the fact that the 10 long-term quitters came from just 4 of the
13 clinics held.
Implications for improving the process
The sub-optimal response rate to the evaluation question-
naires might have been due to participants’ unwillingness to
participate or the facilitators’ omission to distribute the ques-
tionnaires.   However the qualitative analysis did give favourable
results concerning the internal process of the meetings and their
physical and psychological outcomes, emphasising the fact that
behavioural counselling depends heavily on motivational skills.
Recruitment criteria of facilitators therefore should include
communicational, interpersonal and motivational skills, to-
gether with the ability to develop group dynamics.   Besides
appropriate introductory training, facilitators should be pro-
vided also with on-going training to promote good practice and
ensure the best level of care14.
The fact that only 54% (n=134) out of 246 applicants actu-
ally presented themselves for the introductory sessions is prob-
ably due to the long time lag from application to commence-
ment.   One way of tackling this is if clinics were to start on a
more frequent basis (e.g. every month) in one accessible cen-
tral venue.   This system would also result in an increase in the
number of participants starting each clinic and enable optimal
use to be made of the few smoking cessation facilitators avail-
able.
Another positive outcome of a short waiting time is that cli-
ents’ want power and will power would still be fresh and keen
enough to facilitate quitting.   This in turn could minimise the
drop of 25% (n=33) between the introductory and quit sessions,
and possibly improve the result that five out of the thirteen clin-
ics produced no quitters at all by the last session.
Also of concern was the steep decline of 63% (17 out of 27)
in the number of quitters who did not manage to remain smoke-
free for six months after the end of the clinics, with most citing
a stressful situation as the cause.   Here, follow-up support
meetings could be offered at various times (e.g. monthly) after
course-completion, for up to 12 months7,14,16.
Cost-benefit analysis and implications
An important economic aspect of treating tobacco depen-
dence is through the prevention of costly chronic diseases and
their complications, which, besides heart disease, lung disease
and delayed wound healing, include cancer1.   Lung cancer is
known to be the disease most closely associated with tobacco
use, with 90% of cases occurring in smokers19.
The cost incurred by the Maltese public health service dur-
ing 1995 with regard to smokers diagnosed with lung cancer
during that year has been estimated by a university disserta-
tion as Lm 286,00020.   Stopping smoking after many years,
even well into middle age, has been shown to result in a de-
crease in the subsequent risk of lung cancer21.   Using these two
studies, an estimation was made in Table 4 of the savings in
lung cancer treatment (during the first year of diagnosed dis-
ease) that the Maltese public health system will make as a re-
sult of smoking cessation clinics held during the one-year pe-
riod starting in October 1999.   This was of Lm 3245 over one
year, which is more than five times as much as the Lm 632 that
the year’s clinics actually cost to run (see Table 5).
This calculation is based on the assumption that that the
quitters will remain non-smokers in the years ahead.   The cal-
culated savings pertain only to the direct medical costs for the
first year of diagnosed lung cancer disease, and exclude the cost
of all staff time and materials, morbidity costs, non-medical/
external costs (tangible and intangible), and the costs of other
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smoking related diseases (notably cardiovascular and other lung
disease).   Further savings that are not addressed include indi-
vidual benefits (years of life, psychological effects) and costs
(time, transport, pharmacotherapy), together with state costs
(planning, setting up and evaluation of sessions and their even-
tual needs re follow up and training).   Therefore, the potential
savings gained from a smoking cessation programme are much
greater than the odd thousand liri estimated here.
Limitations of study methods
Quantitative
As this study was bound by a time limit, the number of par-
ticipants was small, which could have a dramatic effect on re-
sults.   Since patients are treated in groups, each person’s chance
of success could be influenced by the group which he or she was
part of4.   Validation of cessation through biochemical measures
(e.g. blood nicotine, urinary cotinine and expired-air carbon
monoxide) was not possible due to financial constraints, as was
follow up after one year due to the limited time-span of this
project14.   Finally, due to unavailability of information, further
analysis of the results according to background (e.g. social class
and profession), besides age and sex, could not be carried out.
Qualitative
One limitation could have been the reactivity of participants,
in that the person filling the questionnaire would have wanted
to leave a good impression by giving the facilitator a reply the
former thinks would have pleased the latter (the ‘halo effect’).
A bias could also have been introduced from two aspects: that
of the response (as questionnaire response was guided by dif-
ferent facilitators) and of the interpretation (which the re-
searcher forestalled by avoiding pre-conceived ideas regarding
possible results).
Another limitation that became apparent was that the three
questions in the evaluation form did not allow for any negative
comments or suggestions for improvement.   Correction of this
limitation would allow participants to comment on the process
from all angles, both positive and negative, thus enabling the
programme to benefit from any constructive criticism.
Concluding Recommendations
The recommendations made to the Health Promotion De-
partment for service improvement at the levels of content, op-
erations, finance and strategy are listed in Table 6.   As treat-
ment of tobacco addiction is more cost-beneficial than care of
tobacco-related disease7, smoking cessation services which are
adequately funded should form a key component in a compre-
hensive, effective and sustained programme to stem the tobacco
epidemic17.
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